001     138030
005     20240613162533.0
024 7 _ |a 0375-9245
|2 ISSN
024 7 _ |a 10.1007/s00702-014-1351-7
|2 doi
024 7 _ |a pmid:25520210
|2 pmid
024 7 _ |a 0300-9564
|2 ISSN
024 7 _ |a 1435-1463
|2 ISSN
024 7 _ |a altmetric:3000407
|2 altmetric
024 7 _ |a 0022-3026
|2 ISSN
037 _ _ |a DZNE-2020-04352
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hagen, Katja
|0 P:(DE-2719)2801322
|b 0
|e First author
|u dzne
245 _ _ |a The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders.
260 _ _ |a Wien [u.a.]
|c 2015
|b Springer
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2014-12-18
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2015-08-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1718288683_11705
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Vagus somatosensory evoked potentials (VSEP) have been shown to have higher latencies with aging, which are even more increased in patients with Alzheimer's disease and subjects with mild cognitive impairment compared to age-matched healthy controls. In this study, the association of VSEP with subjective memory impairment (SMI), a potential risk or prodromal marker for Alzheimer's disease, was examined. The association of VSEP latencies and SMI was studied in a healthy risk cohort, including 358 elderly subjects, who are in a longitudinal study of risk factors for neurodegenerative disorders. The results show increased VSEP latencies for peak P2 at Fz-F4 in subjects who report SMI and are worried about it as compared to subjects who report memory impairment, but are not concerned and subjects without complaints. The results support a potential role of VSEP for the detection of very early neurodegenerative processes which may precede Alzheimer's disease.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
542 _ _ |i 2014-12-18
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Alzheimer Disease: diagnosis
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: diagnosis
|2 MeSH
650 _ 2 |a Evoked Potentials, Somatosensory: drug effects
|2 MeSH
650 _ 2 |a Evoked Potentials, Somatosensory: physiology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Memory Disorders: drug therapy
|2 MeSH
650 _ 2 |a Memory Disorders: physiopathology
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Neurodegenerative Diseases: diagnosis
|2 MeSH
650 _ 2 |a Neurodegenerative Diseases: drug therapy
|2 MeSH
650 _ 2 |a Neurodegenerative Diseases: physiopathology
|2 MeSH
650 _ 2 |a Perception
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Risk
|2 MeSH
650 _ 2 |a Vagus Nerve: drug effects
|2 MeSH
650 _ 2 |a Vagus Nerve: physiopathology
|2 MeSH
700 1 _ |a Ehlis, Ann-Christine
|b 1
700 1 _ |a Haeussinger, Florian B
|b 2
700 1 _ |a Beeretz, Stefan
|b 3
700 1 _ |a Kromer, Gina V
|b 4
700 1 _ |a Heinzel, Sebastian
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Maetzler, Walter
|0 P:(DE-2719)2810915
|b 6
|u dzne
700 1 _ |a Eschweiler, Gerhard W
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Berg, Daniela
|0 P:(DE-2719)2000059
|b 8
|u dzne
700 1 _ |a Fallgatter, Andreas J
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Metzger, Florian G
|b 10
700 1 _ |a Consortium, TREND Study
|b 11
773 1 8 |a 10.1007/s00702-014-1351-7
|b : Springer Science and Business Media LLC, 2014-12-18
|n 8
|p 1167-1174
|3 journal-article
|2 Crossref
|t Journal of Neural Transmission
|v 122
|y 2014
|x 0300-9564
773 _ _ |a 10.1007/s00702-014-1351-7
|g Vol. 122, no. 8, p. 1167 - 1174
|0 PERI:(DE-600)1481655-6
|n 8
|q 122:8<1167 - 1174
|p 1167-1174
|t Journal of neural transmission
|v 122
|y 2015
|x 0300-9564
856 4 _ |u https://pub.dzne.de/record/138030/files/DZNE-2020-04352_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/138030/files/DZNE-2020-04352_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:138030
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2801322
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810915
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2000059
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 1
914 1 _ |y 2015
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEURAL TRANSM : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)1240015
|k AG N.N. 3
|l AG N.N.
|x 0
920 1 _ |0 I:(DE-2719)5000024
|k AG Maetzler
|l Functional Neurogeriatrics
|x 1
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg ; AG Berg
|l Parkinson's Disease Genetics
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1240015
980 _ _ |a I:(DE-2719)5000024
980 _ _ |a I:(DE-2719)5000055
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.eurpsy.2008.02.004
|2 Crossref
|o 10.1016/j.eurpsy.2008.02.004
999 C 5 |9 -- missing cx lookup --
|a 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8
|2 Crossref
|o 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0165-0327(00)00309-8
|2 Crossref
|o 10.1016/S0165-0327(00)00309-8
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archpsyc.1961.01710120031004
|2 Crossref
|o 10.1001/archpsyc.1961.01710120031004
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.24985
|2 Crossref
|o 10.1002/mds.24985
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-002-0808-2
|2 Crossref
|o 10.1007/s00702-002-0808-2
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S1355617711001524
|2 Crossref
|o 10.1017/S1355617711001524
999 C 5 |9 -- missing cx lookup --
|a 10.1093/jnen/61.5.413
|2 Crossref
|o 10.1093/jnen/61.5.413
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archgenpsychiatry.2011.80
|2 Crossref
|o 10.1001/archgenpsychiatry.2011.80
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-003-0087-6
|2 Crossref
|o 10.1007/s00702-003-0087-6
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ijpsycho.2004.09.007
|2 Crossref
|o 10.1016/j.ijpsycho.2004.09.007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0022-3956(75)90026-6
|2 Crossref
|o 10.1016/0022-3956(75)90026-6
999 C 5 |y 1999
|2 Crossref
|o MI Geerlings 1999
999 C 5 |9 -- missing cx lookup --
|a 10.1097/WNP.0000000000000038
|2 Crossref
|o 10.1097/WNP.0000000000000038
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e31828726f5
|2 Crossref
|o 10.1212/WNL.0b013e31828726f5
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2012.05.021
|2 Crossref
|o 10.1016/j.neurobiolaging.2012.05.021
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0027831
|2 Crossref
|o 10.1371/journal.pone.0027831
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(09)70299-6
|2 Crossref
|o 10.1016/S1474-4422(09)70299-6
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0013-4694(58)90053-1
|2 Crossref
|o 10.1016/0013-4694(58)90053-1
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2005.10.010
|2 Crossref
|o 10.1016/j.neurobiolaging.2005.10.010
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S0033291707001122
|2 Crossref
|o 10.1017/S0033291707001122
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archgenpsychiatry.2010.30
|2 Crossref
|o 10.1001/archgenpsychiatry.2010.30
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0016852
|2 Crossref
|o 10.1371/journal.pone.0016852
999 C 5 |9 -- missing cx lookup --
|a 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5
|2 Crossref
|o 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S0033291701003245
|2 Crossref
|o 10.1017/S0033291701003245
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S0033291704003162
|2 Crossref
|o 10.1017/S0033291704003162
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.archger.2013.01.005
|2 Crossref
|o 10.1016/j.archger.2013.01.005
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.20009
|2 Crossref
|o 10.1002/ana.20009
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00127-010-0333-9
|2 Crossref
|o 10.1007/s00127-010-0333-9
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000339359
|2 Crossref
|o 10.1159/000339359
999 C 5 |y 1988
|2 Crossref
|o JC Morris 1988
999 C 5 |9 -- missing cx lookup --
|a 10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q
|2 Crossref
|o 10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-007-0625-8
|2 Crossref
|o 10.1007/s00702-007-0625-8
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-009-0282-1
|2 Crossref
|o 10.1007/s00702-009-0282-1
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-009-0202-4
|2 Crossref
|o 10.1007/s00702-009-0202-4
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-011-6084-z
|2 Crossref
|o 10.1007/s00415-011-6084-z
999 C 5 |y 2013
|2 Crossref
|o T Polak 2013
999 C 5 |9 -- missing cx lookup --
|a 10.1097/WNR.0b013e32835f00a3
|2 Crossref
|o 10.1097/WNR.0b013e32835f00a3
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S1041610207006412
|2 Crossref
|o 10.1017/S1041610207006412
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000115751
|2 Crossref
|o 10.1159/000115751
999 C 5 |y 1998
|2 Crossref
|t CAMDEX-R: the Cambridge examination for mental disorders of the elderly
|o M Roth CAMDEX-R: the Cambridge examination for mental disorders of the elderly 1998
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000234032.77541.a2
|2 Crossref
|o 10.1212/01.wnl.0000234032.77541.a2
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e31826c1a8d
|2 Crossref
|o 10.1212/WNL.0b013e31826c1a8d
999 C 5 |9 -- missing cx lookup --
|a 10.1097/YCO.0b013e3283586fd8
|2 Crossref
|o 10.1097/YCO.0b013e3283586fd8
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000264630
|2 Crossref
|o 10.1159/000264630
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S0033291711000067
|2 Crossref
|o 10.1017/S0033291711000067
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000161057
|2 Crossref
|o 10.1159/000161057
999 C 5 |y 2004
|2 Crossref
|o WM Flier van der 2004


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21